Detalhe da pesquisa
1.
Tofacitinib or adalimumab versus placebo in rheumatoid arthritis.
N Engl J Med
; 367(6): 508-19, 2012 Aug 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-22873531
2.
[Economic evaluation of rheumathoid arthritis monotherapy with tocilizumab and adalimumab]. / Evaluación económica de la monoterapia con tocilizumab frente a adalimumab en artritis reumatoide.
Rev Esp Salud Publica
; 87(4): 343-50, 2013.
Artigo
em Espanhol
| MEDLINE | ID: mdl-24100773
3.
Maraviroc, a chemokine receptor-5 antagonist, fails to demonstrate efficacy in the treatment of patients with rheumatoid arthritis in a randomized, double-blind placebo-controlled trial.
Arthritis Res Ther
; 14(1): R11, 2012 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-22251436